Lymphoma Trial, Recruiting (NCT04947618)

Lymphoma Trial, Recruiting NCT04947618 Sponsor: Centre Hospitalier Universitaire de Nīmes Condition: Lymphoma

Printed from Voxsanity (voxsanity.com.au) — NCT04947618 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lymphoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are older than 15 years and 3 months, were diagnosed with lymphoma at Nîmes University Hospital from 1999 onwards, and whose original tumour tissue samples from diagnosis are still available.

Who may not be able to join:

People aged 18 or older who have already said they do not wish to take part in the study.
People under the age of 18 whose parent or legal guardian has said they do not want the child to take part in the study.
People who are under legal guardianship.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anissa MEGZARI, CHU de Nîmes (Nîmes University Hospital)

Phone: 0466684033

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04947618

Sponsor: Centre Hospitalier Universitaire de Nīmes

Phase: Not Applicable

Status: Recruiting

Condition: Lymphoma

Trial contact: 0466684033

More information: https://clinicaltrials.gov/study/NCT04947618

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are older than 15 years and 3 months, were diagnosed with lymphoma at Nîmes University Hospital from 1999 onwards, and whose original tumour tissue samples from diagnosis are still available.

Who may not be able to join:

People aged 18 or older who have already said they do not wish to take part in the study.
People under the age of 18 whose parent or legal guardian has said they do not want the child to take part in the study.
People who are under legal guardianship.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Universitaire de Nīmes

Registry

ClinicalTrials.gov

Start date

22 January 2024

Est. completion

31 January 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Overall survival rate among patients with Hodgkin Lymphomas; Overall survival rate among patients with Mantle-cell Lymphomas; Overall survival rate among patients with Primitive Cerebral Lymphomas; Overall survival rate among patients with Follicular Lymphomas; Overall survival rate among patients with Marginal Zone Lymphomas; Overall survival rate among patients with Waldenström's Disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov